http://www.fpnotebook.com/
Urinary Tract Infection in ChildrenAka: Pediatric UTI, UTI in children
- See Also
- Epidemiology
- UTI Incidence
- Newborns: 0.14%
- Febrile newborns: 7%
- Symptomatic UTI under age 6 years
- Girls: 7%
- Boys: 2%
- School aged children: 1-2%
- Ages 7 to 11 year old females: 2.5%
- Newborns: 0.14%
- Renal abnormality (Vesicoureteral Reflux) Incidence
- School aged children with UTI: 25-40%
- Preschool sibling of child with VUR: 25-33%
- Child of parent with VUR: 65%
- UTI Incidence
- Causes (single organism in most cases)
- Bacteria
- Escherichia coli (60-80%)
- Klebsiella
- Proteus (boys and associated with Nephrolithiasis)
- Enterococcus
- Pseudomonas
- Staphylococcus aureus
- Coagulase negative Staphylococcus
- Viral
- Adenovirus (hemorrhagic cystitis)
- Atypical causes
- Fungal
- Mycobacterium
- Schistosomiasis
- Bacteria
- Indications to evaluate for UTI
- Infants
- Younger age (<3 months)
- Ill appearance
- Fever Without Focus
- Girls or uncircumcised boys
- Persistant fever
- Newman (2002) Arch Pediatr Adolesc Med 156:44
- Children over age 2 years
- Constipation
- Encopresis
- Bladder instability
- Infrequent voiding
- Koff (1998) J Urol 160:1019
- Infants
- Signs and symptoms
- Infant
- Failure to Thrive
- Fever
- Weight Loss
- Nausea or Vomiting
- Irritability
- Jaundice
- Child
- Same as for adult Urinary Tract Infection
- Dysuria
- Urinary frequency or urgency
- Urine hesitancy
- Lower Abdominal Pain
- Urine Odor does not predict Urinary Tract Infection
- Infant
- Diagnosis
- General
- Urinalysis dipstick can be used to rule-out UTI
- High Negative Predictive Value if normal
- Exception: Not sensitive in dilute urine (SG<1.005)
- Shaw (1998) Pediatrics 101:E1
- Urine Culture is required for UTI diagnosis
- Urinalysis dipstick testing is not diagnostic
- Urinalysis dipstick can be used to rule-out UTI
- Urine Sample Techniques
- Clean catch Urine (especially first morning void)
- Possible in infants, but requires patience
- Urine catheter specimen
- Recommended if child under age 2 years
- Suprapubic Aspirate
- Consider for child under age 6 months old
- Urine Bag Collection (Not recommended)
- High Incidence of contamination
- Clean catch Urine (especially first morning void)
- Urinalysis (Sensitivity, Specificity)
- Urine Leukocyte Esterase (small or greater)
- Sensitivity: 83%
- Specificity: 95%
- Urine Nitrite
- Sensitivity: 27%
- Specificity: 98%
- Urine White Blood Cells (5 or greater) on microscopy
- Sensitivity: 86%
- Specificity: 79%
- Urine bacteria present on microscopy
- Sensitivity: 93%
- Specificity: 40%
- Urine Leukocyte Esterase (small or greater)
- Urine Culture
- See Urine Culture for diagnostic criteria
- General
- Labs
- Standard
- Suspected Pyelonephritis
- Complete Blood Count (CBC)
- Blood Culture
- Indicated for febrile hospitalized child
- UTI with bacteremia requires earlier imaging
- Inflammation Markers (70-80 sensitive, not specific)
- Renal Function tests)
- Radiology
- General
- First UTI in age <5 may no longer require imaging
- Does not appear to change management or outcome
- Zamir (2004) Arch Dis Child 89:466
- Available studies for anomalies in acute UTI
- Renal and Bladder Ultrasound
- DMSA Renal Cortical Scan
- Avoid VCUG during acute infection
- General
- Management: Prevent renal scars in high risk children
- Children under age 2 years
- Recurrent Pyelonephritis
- Pyelonephritis with urinary anatomic abnormality
- Pyelonephritis untreated for more than 3 days
- Management: Inpatient criteria
- Ill appearing or toxic children
- Children unable to maintain oral hydration
- Risk of renal scar
- Febrile children under age 6 months to 1 year old
- Management: Antibiotics
- Oral antibiotics for 10 to 14 days
- Amoxicillin 20-40 mg/kg/day divided tid
- First choice antibiotic in age <2 months
- Amoxicillin-clavulonate (Augmentin)
- Trimethoprim Sulfamethoxazole (Septra, Bactrim)
- Dosing: 6-12 mg/kg TMP,30-60 mg/kg SMZ divided bid
- Avoid under age 2 months
- Poor renal penetration
- Second generation or Third Generation Cephalosporins
- Cefixime (Suprax) 8 mg/kg divided bid
- Cefpodoxime (Vantin) 10 mg/kg divided bid
- Cefprozil (Cefzil) 30 mg/kg divided bid
- Cephalexin (Keflex) 50-100 mg/kg divided qid
- Loracarbef (Lorabid) 15-30 mg/kg divided bid
- Amoxicillin 20-40 mg/kg/day divided tid
- Intravenous antibiotics for hospitalized children
- Gentamicin
- Cefotaxime
- Cefuroxime
- Cefixime
- Ceftriaxone (Rocephin)
- Ampicillin-Sulbactam (Unasyn)
- Oral antibiotics for 10 to 14 days
- Management: UTI Prophylaxis
- Indications
- Risk of vesicoureteral reflux (until evaluation)
- Medications (at bedtime if toilet trained)
- Trimethoprim Sulfamethoxazole (Septra, Bactrim)
- Avoid under 2 months
- Dosing
- Nightly: 2 mg TMP/10 mg SMZ per kg at bedtime
- Bi-weekly: 5 mg TMP/25 mg SMZ per kg twice weekly
- Nitrofurantoin (Furadantin, Macrodantin, Macrobid)
- Dosing: 1-2 mg/kg once daily
- Nalidixic Acid (NegGram)
- Dosing: 30 mg/kg/day divided bid
- Methenamine mandelate 75 mg/kg/day divided bid
- Sulfisoxazole (Gantrisin) 10-20 mg/kg/day divided bid
- Trimethoprim Sulfamethoxazole (Septra, Bactrim)
- Other prevention
- Circumcision in uncircumsized boys
- Indications
- Management: Evaluation for secondary urologic anomaly
- Indications (recommendations are currently in flux)
- Single Urinary Tract Infection under age 2 years
- More than one Urinary Tract Infection under age 10
- Preschool siblings of child with urologic anomaly
- Preschool child of parent with vesicoureteral reflux
- Protocol
- Renal and bladder Ultrasound
- Voiding Cystourethrogram (VCUG)
- Indicated for children under age 5 years
- Obtain 3-6 weeks after UTI
- DMSA Renal Cortical Scan
- Indicated for girls (spares ovarian radiation)
- Indicated for assessment of renal scarring
- Indications (recommendations are currently in flux)
- Prognosis: Vesicoureteral Reflux
- Risk End-stage renal disease if renal scarring occurs
- Responsible for 20% of end-stage renal disease
- Spontaneous Resolution Rates for Ureteral Reflux
- Grade I: 70-80%
- Grade II: 70-80%
- Grade III: 50%
- Grade IV: 15%
- Grade V: <15%
- Risk End-stage renal disease if renal scarring occurs
- References
- Alper (2005) Am Fam Physician 72:2483
- Bulloch (2000) Pediatrics 106:e60
- Fisher (1999) Pediatrics 104:109
- Hoberman (1999) Pediatr Infect Dis J 18:1020
- Hoberman (1999) Pediatrics 104:79
- Honkinen (2000) Pediatr Infect Dis 19:630
- Roberts (2000) Am Fam Physician 62(8):1815
- Ross (1999) Am Fam Physician 59(6):1472